메뉴 건너뛰기
Nature Clinical Practice Oncology
Volumn 4, Issue 4, 2007, Pages 204-205
Hormone receptors in defining breast cancer prognosis - Time for a rethink?
Author keywords

[No Author keywords available]
Indexed keywords

ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GROWTH FACTOR RECEPTOR; HORMONE RECEPTOR; PHOSPHOTRANSFERASE; PROGESTERONE RECEPTOR A; PROGESTERONE RECEPTOR B; TAMOXIFEN;
EID: 34047185378     PISSN: 17434254     EISSN: 17434262     Source Type: Journal    
DOI: 10.1038/ncponc0771     Document Type: Review
Times cited : (5)
References (10)
  • 1
    • 19344364880 scopus 로고    scopus 로고
    • Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials
    • Eady Breast Cancer Trialists' Collaborative Group
    • Eady Breast Cancer Trialists' Collaborative Group (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials. Lancet 365: 1687-1717
    • (2005) Lancet , vol.365 , pp. 1687-1717
  • 2
    • 33748346434 scopus 로고    scopus 로고
    • Estrogen receptor (ER)-β isoforms: A key to understanding ER-β signaling
    • Leung YK et al. (2006) Estrogen receptor (ER)-β isoforms: A key to understanding ER-β signaling. Proc Natl Acad Sci USA 103: 13162-13167
    • (2006) Proc Natl Acad Sci USA , vol.103 , pp. 13162-13167
    • Leung, Y.K.1
  • 3
    • 1342330354 scopus 로고    scopus 로고
    • Oestrogen receptor β: What it means for patients with breast cancer
    • Erratum in: Lancet Oncol (2004) 5: 208
    • Speirs V et al. (2004) Oestrogen receptor β: What it means for patients with breast cancer. Lancet Oncol 5: 174-181. Erratum in: Lancet Oncol (2004) 5: 208
    • (2004) Lancet Oncol , vol.5 , pp. 174-181
    • Speirs, V.1
  • 4
    • 11144354862 scopus 로고    scopus 로고
    • The expression of ERβcx in human breast cancer and the relationship to endocrine therapy and survival
    • Palmieri C et al. (2004) The expression of ERβcx in human breast cancer and the relationship to endocrine therapy and survival. Clin Cancer Res 10: 2421-2428
    • (2004) Clin Cancer Res , vol.10 , pp. 2421-2428
    • Palmieri, C.1
  • 5
    • 18344367284 scopus 로고    scopus 로고
    • Increased estrogen receptor βcx expression during mammary carcinogenesis
    • Esslimai-Sahla M et al. (2005) Increased estrogen receptor βcx expression during mammary carcinogenesis. Clin Cancer Res 11: 3170-3174
    • (2005) Clin Cancer Res , vol.11 , pp. 3170-3174
    • Esslimai-Sahla, M.1
  • 6
    • 32944482243 scopus 로고    scopus 로고
    • Biology of progesterone receptor loss in breast cancer and its implications for endocrine therapy
    • Cui X et al. (2005) Biology of progesterone receptor loss in breast cancer and its implications for endocrine therapy. J Clin Oncol 23: 7721-7735
    • (2005) J Clin Oncol , vol.23 , pp. 7721-7735
    • Cui, X.1
  • 7
    • 9344264630 scopus 로고    scopus 로고
    • Low levels of estrogen receptor β protein predict resistance to tamoxifen therapy in breast cancer
    • Hopp TA et al. (2004) Low levels of estrogen receptor β protein predict resistance to tamoxifen therapy in breast cancer. Clin Cancer Res 10: 7490-7499
    • (2004) Clin Cancer Res , vol.10 , pp. 7490-7499
    • Hopp, T.A.1
  • 8
    • 0036112855 scopus 로고    scopus 로고
    • Loss of co-ordinate expression of progesterone receptors A and B is an early event in breast carcinogenesis
    • Mote PA et al. (2002) Loss of co-ordinate expression of progesterone receptors A and B is an early event in breast carcinogenesis. Breast Cancer Res Treat 72: 163-172
    • (2002) Breast Cancer Res Treat , vol.72 , pp. 163-172
    • Mote, P.A.1
  • 9
    • 33847277446 scopus 로고    scopus 로고
    • The use of gene-expression profiling to better understand the clinical heterogeneity of estrogen receptor positive breast cancers and tamoxifen response
    • Loi S et al. (2007) The use of gene-expression profiling to better understand the clinical heterogeneity of estrogen receptor positive breast cancers and tamoxifen response. Crit Rev Oncol Hematol 61: 187-194
    • (2007) Crit Rev Oncol Hematol , vol.61 , pp. 187-194
    • Loi, S.1
  • 10
    • 33646255471 scopus 로고    scopus 로고
    • A two-gene expression ratio of homeobox 13 and interleukin-17B receptor for prediction of recurrence and survival in women receiving adjuvant tamoxifen
    • Goetz MP et al. (2006) A two-gene expression ratio of homeobox 13 and interleukin-17B receptor for prediction of recurrence and survival in women receiving adjuvant tamoxifen. Clin Cancer Res 12: 2080-2087
    • (2006) Clin Cancer Res , vol.12 , pp. 2080-2087
    • Goetz, M.P.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.